Litcius/Paper detail

Materiovigilance Programme of India

P. K. Saifuddin, Moksh Tandon, Vivekanandan Kalaiselvan, Benjamin Suroy, Vidya Pattanshetti, Ajay Prakash, Bikash Medhi

2022Indian Journal of Pharmacology25 citationsDOIOpen Access PDF

Abstract

Postmarketing vigilance system for medical devices in India is not as vigorous as of drugs. W Materiovigilance involves post marketing surveillance of adverse events caused by medical devices. As per directive of WHO, many countries including India have established their own post marketing surveillance system. In India it is known as Materiovigilance Programme of India (MvPI). This article reviews the current state of MvPI, compares it with developed countries, identifies gaps, and recommends specific measure to strengthen the existing program.

Topics & Concepts

Postmarketing surveillanceDirectiveBusinessMedicineAdverse effectComputer sciencePharmacologyProgramming languageQuality and Safety in Healthcare